Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART

Catia Cillóniz, Antonella Ielpo, Antoni Torres

Producción científica: Artículo CientíficoArtículo de revisiónrevisión exhaustiva

1 Cita (Scopus)


Purpose of Review: This article reviews the most recent publications on community-acquired pneumonia (CAP) in the HIV-infected population on antiretroviral therapy (ART), focusing on epidemiology, prognostic factors, etiology, and antimicrobial therapy. The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles. Recent Findings: CAP remains a major cause of morbidity and mortality among HIV-infected patients and incurs high health costs despite the introduction of ART. Summary: HIV-infected patients are generally known to be more susceptible to bacterial pneumonia. Streptococcus pneumoniae is the most frequently reported pathogen in HIV-infected patients on ART, who present a higher rate of bacteremia than non-HIV-infected patients. Several studies have also examined microbial etiology and prognostic factors of CAP in HIV-infected patients on ART. Despite the high rate of bacterial pneumonia in these patients, mortality rates are not higher than in patients without HIV infection.

Idioma originalInglés estadounidense
PublicaciónCurrent Infectious Disease Reports
EstadoIndizado - 1 nov. 2018
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.


Profundice en los temas de investigación de 'Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART'. En conjunto forman una huella única.

Citar esto